These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Two to tango: GPCR oligomers and GPCR-TRP channel interactions in nociception. Yekkirala AS Life Sci; 2013 Mar; 92(8-9):438-45. PubMed ID: 22771696 [TBL] [Abstract][Full Text] [Related]
44. G protein-coupled receptor modulation with pepducins: moving closer to the clinic. Dimond P; Carlson K; Bouvier M; Gerard C; Xu L; Covic L; Agarwal A; Ernst OP; Janz JM; Schwartz TW; Gardella TJ; Milligan G; Kuliopulos A; Sakmar TP; Hunt SW Ann N Y Acad Sci; 2011 May; 1226():34-49. PubMed ID: 21615752 [TBL] [Abstract][Full Text] [Related]
45. Cannabinoid receptor homo- and heterodimerization. Mackie K Life Sci; 2005 Aug; 77(14):1667-73. PubMed ID: 15978631 [TBL] [Abstract][Full Text] [Related]
46. Neuronal functions of activators of G protein signaling. Tse MK; Wong YH Neurosignals; 2013; 21(3-4):259-71. PubMed ID: 22571923 [TBL] [Abstract][Full Text] [Related]
47. Modulating receptor function through RAMPs: can they represent drug targets in themselves? Sexton PM; Poyner DR; Simms J; Christopoulos A; Hay DL Drug Discov Today; 2009 Apr; 14(7-8):413-9. PubMed ID: 19150656 [TBL] [Abstract][Full Text] [Related]
48. The role of the Mrgpr receptor family in itch. Liu Q; Dong X Handb Exp Pharmacol; 2015; 226():71-88. PubMed ID: 25861775 [TBL] [Abstract][Full Text] [Related]
49. Mas-Related G Protein-Coupled Receptors (Mrgprs) as Mediators of Gut Neuro-Immune Signaling. Van Remoortel S; Timmermans JP Adv Exp Med Biol; 2022; 1383():259-269. PubMed ID: 36587165 [TBL] [Abstract][Full Text] [Related]
50. Contribution of heteromerization to G protein-coupled receptor function. Gaitonde SA; González-Maeso J Curr Opin Pharmacol; 2017 Feb; 32():23-31. PubMed ID: 27835800 [TBL] [Abstract][Full Text] [Related]
51. Adhesion G Protein-Coupled Receptors as Drug Targets for Neurological Diseases. Folts CJ; Giera S; Li T; Piao X Trends Pharmacol Sci; 2019 Apr; 40(4):278-293. PubMed ID: 30871735 [TBL] [Abstract][Full Text] [Related]
52. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Milligan G Br J Pharmacol; 2009 Sep; 158(1):5-14. PubMed ID: 19309353 [TBL] [Abstract][Full Text] [Related]
53. International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Davenport AP; Alexander SP; Sharman JL; Pawson AJ; Benson HE; Monaghan AE; Liew WC; Mpamhanga CP; Bonner TI; Neubig RR; Pin JP; Spedding M; Harmar AJ Pharmacol Rev; 2013 Jul; 65(3):967-86. PubMed ID: 23686350 [TBL] [Abstract][Full Text] [Related]
54. Nonpeptide ligands for peptidergic G protein-coupled receptors. Geary TG Adv Exp Med Biol; 2010; 692():10-26. PubMed ID: 21189672 [TBL] [Abstract][Full Text] [Related]
56. Ligand-selective signaling and high-content screening for GPCR drugs. Gurwitz D; Haring R Drug Discov Today; 2003 Dec; 8(24):1108-9. PubMed ID: 14678735 [No Abstract] [Full Text] [Related]
57. Extra sensory perception: the role of Gpr receptors in the kidney. Pluznick JL Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):507-12. PubMed ID: 25023949 [TBL] [Abstract][Full Text] [Related]
58. Isolation of new ligands for orphan receptor MRGPRX1-hemorphins LVV-H7 and VV-H7. Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH Peptides; 2017 Oct; 96():61-66. PubMed ID: 28867075 [TBL] [Abstract][Full Text] [Related]